Veru Inc (VERU) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Veru Inc stock (VERU) is currently trading at $2.29. Veru Inc PS ratio (Price-to-Sales) is 1.79. Analyst consensus price target for VERU is $25.00. WallStSmart rates VERU as Sell.
- VERU PE ratio analysis and historical PE chart
- VERU PS ratio (Price-to-Sales) history and trend
- VERU intrinsic value — DCF, Graham Number, EPV models
- VERU stock price prediction 2025 2026 2027 2028 2029 2030
- VERU fair value vs current price
- VERU insider transactions and insider buying
- Is VERU undervalued or overvalued?
- Veru Inc financial analysis — revenue, earnings, cash flow
- VERU Piotroski F-Score and Altman Z-Score
- VERU analyst price target and Smart Rating
Veru Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Veru Inc (VERU) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and peg ratio. Mixed signals suggest waiting for clearer direction before acting.
Veru Inc (VERU) Key Strengths (2)
Trading below book value, meaning the market prices it less than net assets
Paying $1.79 for every $1 of annual revenue
Supporting Valuation Data
Veru Inc (VERU) Areas to Watch (5)
Company is destroying shareholder value
Very expensive relative to growth, significant premium
Micro-cap company with very limited liquidity and high volatility
Low institutional interest, mostly retail-driven
Solid revenue growth at 18.30% per year
Supporting Valuation Data
Veru Inc (VERU) Detailed Analysis Report
Overall Assessment
This company scores 36/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 2 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Price/Sales. Valuation metrics including Price/Sales (1.79), Price/Book (0.99) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, PEG Ratio, Market Cap. Some valuation metrics including PEG Ratio (3.60) suggest expensive pricing. Growth concerns include Revenue Growth at 18.30%, which may limit upside. Profitability pressure is visible in Return on Equity at -60.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -60.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 18.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and PEG Ratio are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
VERU Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
VERU's Price-to-Sales ratio of 1.79x trades 28% below its historical average of 2.48x (31th percentile). The current valuation is 66% below its historical high of 5.27x set in Apr 2014, and 193% above its historical low of 0.61x in Jan 2016.
WallStSmart Analysis Synopsis
Data-driven financial summary for Veru Inc (VERU) · HEALTHCARE › BIOTECHNOLOGY
The Big Picture
Veru Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 17M with 18% growth year-over-year.
Key Findings
Free cash flow is -6M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor BIOTECHNOLOGY industry trends, competitive moves, and regulatory changes that could impact Veru Inc.
Bottom Line
Veru Inc offers an attractive blend of growth (18% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(0 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 10:06:46 AM
About Veru Inc(VERU)
NASDAQ
HEALTHCARE
BIOTECHNOLOGY
USA
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.